DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,401,159 | -0.4% | 5,608 | -0.4% | 0.83% | +0.4% |
Q1 2024 | $1,406,424 | +6.4% | 5,632 | -1.4% | 0.82% | -3.9% |
Q4 2023 | $1,321,415 | -8.5% | 5,712 | -1.9% | 0.86% | -16.9% |
Q3 2023 | $1,444,935 | +3.4% | 5,824 | 0.0% | 1.03% | +10.4% |
Q2 2023 | $1,397,760 | -4.8% | 5,824 | 0.0% | 0.93% | -8.9% |
Q1 2023 | $1,467,881 | -5.0% | 5,824 | 0.0% | 1.02% | -6.8% |
Q4 2022 | $1,545,806 | +5.9% | 5,824 | +3.1% | 1.10% | -5.6% |
Q3 2022 | $1,459,000 | +1.9% | 5,649 | 0.0% | 1.16% | +10.1% |
Q2 2022 | $1,432,000 | -14.4% | 5,649 | -0.9% | 1.06% | +8.2% |
Q1 2022 | $1,672,000 | -12.3% | 5,699 | -1.6% | 0.98% | -1.6% |
Q4 2021 | $1,906,000 | +8.7% | 5,794 | +0.6% | 0.99% | -1.8% |
Q3 2021 | $1,754,000 | +12.9% | 5,762 | -0.5% | 1.01% | +15.0% |
Q2 2021 | $1,554,000 | +26.4% | 5,792 | +6.1% | 0.88% | +10.6% |
Q1 2021 | $1,229,000 | +4.9% | 5,459 | +3.5% | 0.80% | -6.5% |
Q4 2020 | $1,172,000 | +9.4% | 5,274 | +6.0% | 0.85% | -13.1% |
Q3 2020 | $1,071,000 | +26.9% | 4,974 | +4.2% | 0.98% | +5.3% |
Q2 2020 | $844,000 | +27.7% | 4,774 | 0.0% | 0.93% | +11.7% |
Q1 2020 | $661,000 | -11.2% | 4,774 | -1.5% | 0.83% | +34.6% |
Q4 2019 | $744,000 | +12.0% | 4,849 | +5.4% | 0.62% | -2.5% |
Q3 2019 | $664,000 | +9.9% | 4,599 | +8.9% | 0.63% | +8.7% |
Q2 2019 | $604,000 | +8.2% | 4,224 | 0.0% | 0.58% | +1.4% |
Q1 2019 | $558,000 | +31.9% | 4,224 | +2.9% | 0.58% | +9.9% |
Q4 2018 | $423,000 | – | 4,104 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |